綠城中國(03900.HK)7月銷售金額約121億元人民幣
綠城中國(03900.HK)公布,7月份取得銷售3,506套,銷售面積約47萬平方米。當月銷售金額約為121億元人民幣(下同),銷售均價約為每平方米25,588元。
首七個月,綠城取得合同銷售面積約312萬平方米,合同銷售金額約787億元,其中歸屬於集團(包括綠城中國控股有限公司及其附屬公司)的權益金額約為450億元。
7月底止,集團另有累計已簽認購協議未轉銷售合同的金額約38億元,其中歸屬於集團的權益金額約為20億元。
7月綠城以綠城品牌銷售的代建管理項目取得合同銷售面積約46萬平方米,合同銷售金額約63億元。2020年1-7月,綠城集團代建項目累計取得合同銷售面積約212萬平方米,合同銷售金額約為314億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.